EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Leserbrief

Letter re: Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial

Erkan Topkan, Efsun Somay, Ugur Selek, Berrin Pehlivan

European Journal of Cancer · 2024

DOI: 10.1016/j.ejca.2023.113459 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift European Journal of Cancer, 2024. Verfasst von Erkan Topkan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Faculty of Medicine, Baskent University, Adana, Turkey. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Nasopharyngeal Neoplasms. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsNasopharyngeal NeoplasmsHumansNasopharyngeal CarcinomaHerpesvirus 4, HumanDNADNA, Viral

Substanzen

DNADNA, Viral

Autor:innen und Institutionen

  • Department of Radiation Oncology, Faculty of Medicine, Baskent University, Adana, Turkey.
  • Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Ankara, Turkey; Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, University of Kyrenia, Girne, North Cyprus. Ele…
  • Department of Radiation Oncology, Faculty of Medicine, Koc University, Istanbul, Turkey.
  • Department of Radiation Oncology, Faculty of Medicine, Bahcesehir University, Istanbul, Turkey.

Zitieren

APA

Topkan, E., Somay, E., Selek, U., & Pehlivan, B. (2024). Letter re: Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.113459

Vancouver

Topkan E, Somay E, Selek U, Pehlivan B. Letter re: Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial. European Journal of Cancer. 2024. doi:10.1016/j.ejca.2023.113459

BibTeX
@article{Topkan2024,
  author = {Topkan, Erkan and Somay, Efsun and Selek, Ugur and Pehlivan, Berrin},
  title = {Letter re: Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial},
  journal = {European Journal of Cancer},
  year = {2024},
  doi = {10.1016/j.ejca.2023.113459}
}
Kostenlos starten →